Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (11)

2022

  1. Further Validation of the Spanish Parent-Reported Child Problematic Traits Inventory: Discriminant Validity for Distinguishing Children Vulnerable to Externalizing and Other Psychopathology Conditions

    Journal of Psychopathology and Behavioral Assessment, Vol. 44, Núm. 1, pp. 245-260

  2. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Obesity does not increase the risk of Asthma readmissions

    Journal of Clinical Medicine, Vol. 9, Núm. 1

2018

  1. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding

    European Journal of Clinical Pharmacology, Vol. 74, Núm. 11, pp. 1503-1511

2017

  1. Asthma exacerbations: factors related to longer hospital stay

    Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, Vol. 72, Núm. 6, pp. 379-384

2011

  1. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: A case-control study

    PLoS ONE, Vol. 6, Núm. 5

2010

  1. Relation between temperature and mortality in thirteen Spanish cities

    International Journal of Environmental Research and Public Health, Vol. 7, Núm. 8, pp. 3196-3210

2009

  1. Influencia de la reserva cognitiva en el rendimiento neuropsicológico de los pacientes con epilepsia

    Medicina Clinica, Vol. 132, Núm. 12, pp. 459-462

  2. Prevalence of CYP2C9 polymorphisms in the south of Europe

    Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 306-310

2008

  1. CYP2D6-GENE POLYMORPHISMS ARE NOT RELATED TO INCREASED GASTROINTESTINAL HEMORRHAGE RISK IN USERS OF SSRI

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY